Robotic Surgery for Urological Cancers: Where Does It Actually Add Value?

This can serve as a pillar article linking to future pages on robotic prostatectomy, partial nephrectomy, radical cystectomy, RPLND, adrenalectomy, etc.

Robotic Surgery for Urological Cancers: Where Does It Actually Add Value?

Robotic surgery is increasingly used in the treatment of prostate, kidney, bladder and selected other urological cancers. Patients often encounter terms such as robotic surgery, laparoscopic surgery and open surgery while exploring their treatment options.

A common question is:

“Is robotic surgery actually better, or is it simply newer technology?”

The answer requires some nuance.

The robot itself does not treat cancer and does not replace the surgeon. It is a surgical platform that allows the surgeon to perform complex minimally invasive procedures with magnified three-dimensional vision, articulated instruments and precise movements.

Its value depends on the operation being performed, the patient's disease, and the experience of the surgical team.

What Is Robotic Surgery?

In conventional open surgery, the surgeon operates through an incision using instruments held directly in the hands.

In conventional laparoscopy, surgery is performed through small ports using long, relatively rigid instruments while viewing the operation on a monitor.

In robotic surgery, small ports are similarly placed in the abdomen. The surgeon sits at a console and controls robotic instruments positioned inside the patient.

Modern robotic platforms provide:

• Magnified three-dimensional vision
• Wristed instruments with a wide range of movement
• Tremor filtration
• Fine dissection in confined anatomical spaces
• Improved ergonomics for complex minimally invasive procedures

Importantly, the robot does not operate independently. Every surgical movement is controlled by the surgeon.

Why Is Robotic Surgery Particularly Useful in Urology?

Many urological organs lie deep within anatomically restricted spaces.

The prostate, for example, is located deep in the male pelvis and is surrounded by structures important for urinary continence and sexual function.

Similarly, kidney surgery may require precise removal of a tumour while preserving as much functioning kidney as possible.

These are situations in which enhanced visualisation and instrument articulation can be particularly useful.

1. Robotic Radical Prostatectomy for Prostate Cancer

Robot-assisted radical prostatectomy (RARP) is one of the most established applications of robotic surgery in uro-oncology.

During radical prostatectomy, the prostate and seminal vesicles are removed, with pelvic lymph-node dissection performed when oncologically indicated.

The operation requires careful dissection around:

• The urinary sphincter
• Bladder neck
• Neurovascular bundles
• Rectum
• Pelvic vessels

Robotic magnification and articulated instruments facilitate precise dissection and reconstruction within this confined space.

Compared with open radical prostatectomy, robotic surgery is generally associated with lower blood loss and shorter hospital stay, while cancer control remains primarily dependent on appropriate patient selection and sound oncological surgery.

Does Robotic Surgery Guarantee Continence or Preservation of Erections?

No.

Urinary continence and erectile-function recovery depend on several factors, including:

• Age
• Baseline function
• Cancer extent
• Anatomy
• Whether nerve-sparing is oncologically appropriate
• Surgical technique and experience

Robotic technology can facilitate precise dissection, but it cannot guarantee a functional outcome.

2. Robotic Partial Nephrectomy for Kidney Cancer

For appropriately selected small renal tumours, partial nephrectomy removes the tumour while preserving the remainder of the kidney.

This is an operation where robotic technology can be particularly useful.

The surgeon may need to:

1. Identify the renal tumour accurately
2. Control the kidney's blood supply temporarily when required
3. Excise the tumour with an appropriate margin
4. Control bleeding
5. Reconstruct the remaining kidney

Robotic instrumentation facilitates tumour excision and intracorporeal suturing, particularly for anatomically complex renal masses.

The important oncological principle, however, remains:

Preserve the kidney when appropriate without compromising cancer control.

3. Robotic Radical Cystectomy for Bladder Cancer

Radical cystectomy is one of the most complex operations in urological oncology.

It involves removal of the urinary bladder, pelvic lymph-node dissection and creation of a new pathway for urine—such as an ileal conduit, neobladder or other urinary diversion, depending on the patient.

Robotic radical cystectomy allows the extirpative component of this major operation to be performed minimally invasively.

However, this remains major cancer surgery, irrespective of whether it is performed robotically or through an open approach.

Patient selection, perioperative optimisation, lymph-node dissection, urinary diversion technique and postoperative recovery pathways remain fundamental.

4. Robotic Surgery for Upper Urinary Tract Cancers

Selected cancers of the renal pelvis and ureter can also be treated robotically.

Depending upon tumour location and risk category, procedures may include:

• Radical nephroureterectomy
• Distal ureterectomy
• Segmental ureterectomy
• Reconstructive procedures in carefully selected cases

The robotic platform can be particularly helpful when cancer surgery must be combined with urinary tract reconstruction.

5. Robotic Retroperitoneal Lymph Node Dissection

Retroperitoneal lymph-node dissection (RPLND) may be required in selected patients with testicular germ-cell tumours.

This is technically demanding surgery because major blood vessels—including the aorta and inferior vena cava—lie within the operative field.

Minimally invasive or robotic RPLND may be considered in carefully selected patients at experienced centres, but it should not be viewed as a universal replacement for open RPLND.

Oncological appropriateness remains more important than the surgical approach.

6. Robotic Surgery for Adrenal and Other Complex Tumours

Robotic surgery can also be used for selected adrenal tumours and other complex retroperitoneal operations.

The potential advantage again lies in performing detailed dissection around important vascular and anatomical structures through a minimally invasive approach.

However, very large tumours, locally invasive cancers or cases involving major vascular structures may still require an open approach.

What Are the Potential Advantages of Robotic Surgery?

Depending on the procedure and patient, potential advantages of minimally invasive robotic surgery may include:

• Smaller incisions
• Reduced blood loss
• Less postoperative pain in some settings
• Earlier mobilisation
• Shorter hospital stay
• Faster return to routine activity

But these advantages should not be confused with superior cancer cure in every situation.

Is Robotic Cancer Surgery Oncologically Better Than Open Surgery?

Not necessarily.

For most established uro-oncological procedures, the goal of robotic surgery is to achieve the same fundamental oncological principles through a minimally invasive approach.

Those principles include:

• Complete removal of the cancer when surgery is intended to be curative
• Appropriate surgical margins
• Adequate lymph-node dissection when indicated
• Preservation of normal organs and function when oncologically safe

The choice of surgical approach should never compromise these principles merely to perform the operation robotically.

Is Robotic Surgery Suitable for Every Urological Cancer?

No.

There are situations where open surgery may be more appropriate.

These can include selected:

• Very large tumours
• Locally invasive cancers
• Major vascular involvement
• Extensive previous abdominal surgery
• Complex salvage procedures
• Situations requiring major multivisceral resection

Conversely, many complex cases previously considered suitable only for open surgery can now be performed robotically in experienced hands.

The decision should therefore be case-specific rather than technology-driven.

Is Robotic Surgery the Same as Artificial Intelligence?

No.

This is another common misconception.

During conventional robotic surgery, the robot does not decide where to cut, identify the cancer independently or perform the operation autonomously.

The surgeon remains in complete control of the instruments throughout the procedure.

Robotic surgery is better understood as an advanced surgical interface that translates the surgeon's hand movements into precise movements inside the patient's body.

Does the Robot Matter More Than the Surgeon?

The surgical platform matters, but surgeon and team experience remain fundamental.

A sophisticated robotic platform cannot compensate for inappropriate patient selection, poor understanding of anatomy or inadequate oncological technique.

When considering robotic cancer surgery, patients should therefore ask not only:

“Is robotic surgery available?”

but also:

“Is robotic surgery appropriate for my cancer, and does my surgical team regularly perform this particular operation?”

What Should a Patient Ask Before Robotic Cancer Surgery?

Useful questions include:

• Why is surgery recommended for my cancer?
• Why is a robotic approach appropriate in my case?
• What would be the alternative open or laparoscopic approach?
• Is organ preservation possible?
• Will lymph-node dissection be required?
• What are the major complications of this particular operation?
• What should I expect regarding hospital stay and recovery?
• Could the operation need conversion to open surgery?
• What are the expected oncological and functional outcomes?

These questions are more useful than choosing an operation solely because it carries the word “robotic.”

The Take-Home Message

Robotic surgery has become an important tool in modern uro-oncology, particularly for procedures requiring precise dissection and reconstruction in anatomically confined areas.

Its greatest value is not simply that the incisions are smaller.

The real objective is to combine the principles of sound cancer surgery with the benefits of a minimally invasive approach—when this can be achieved safely and appropriately.

For prostate, kidney, bladder and selected other urological cancers, robotic surgery can offer important advantages in appropriately selected patients.

But the fundamental question should always remain:

“What is the best oncologically appropriate operation for this particular patient?”

—not simply—

“Can this operation be done robotically?”

About the Author

Dr. Anshuman Singh
M.S., M.Ch. Urology (Gold Medalist)
Fellowship – Uro-Oncology & Robotic Surgery (USI, Intuitive Certified)
Visiting Fellow – Robotic Uro-Oncology (Fundació Puigvert, Spain)
Clinical Observer – Robotic Pelvic Oncology (University College Hospitals London)
Vice Chairperson – Uro-Oncology & Robotic Surgery
Chandan Cancer Institute, Chandan Hospital
Lucknow

Suggested references

1. European Association of Urology. EAU Guidelines. 2026.
2. Yaxley JW, Coughlin GD, Chambers SK, et al. Robot-assisted laparoscopic prostatectomy versus open radical retropubic prostatectomy: early outcomes from a randomised controlled phase 3 study. Lancet. 2016;388:1057–1066.
3. Parekh DJ, Reis IM, Castle EP, et al. Robot-assisted radical cystectomy versus open radical cystectomy in patients with bladder cancer (RAZOR). Lancet. 2018;391:2525–2536.
4. Catto JWF, Khetrapal P, Ricciardi F, et al. Effect of robot-assisted radical cystectomy with intracorporeal urinary diversion vs open radical cystectomy on 90-day morbidity and mortality (iROC). JAMA. 2022;327:2092–2103.